Exagen Inc. to Participate in Upcoming Investor Conferences

Weekly Voice editorial staff
0 Min Read

CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences:

- Advertisement -
Share This Article